Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Transition Preparation Intervention for Young Adults With Type 1 Diabetes

5. november 2020 opdateret af: Virginia Commonwealth University

Implementing a Transition Preparation Intervention for Young Adults With Type 1 Diabetes in an Integrated Healthcare Setting

The purpose of this research study is to find out more about how to support young adults (ages 18-22) with type 1 diabetes as they prepare to transition from pediatric and adult endocrinology medical care.

Studieoversigt

Status

Afsluttet

Betingelser

Intervention / Behandling

Detaljeret beskrivelse

The overarching goal of the proposed trial is to improve diabetes self-management and glycemic control in young adults and prepare them for the transition to adult endocrinology. The current application will investigate the impact of a multisystem transition preparation intervention for young adults (ages 18-22) with T1D. Twenty-five young adults and a parent will be enrolled in a 6-month transition preparation program which will use a hybrid in-person and technology delivery structure. Providers will receive training highlighting their role preparing young adults for transition and provides practical tips to use in their communication with young adults. If effective, this multisystem intervention, designed to enhance T1D self-management and increase young adults' readiness for transition to adult healthcare during this critical developmental period, has the potential to inform clinical practice guidelines.

Undersøgelsestype

Interventionel

Tilmelding (Faktiske)

62

Fase

  • Ikke anvendelig

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiesteder

  • Forenede Stater
    • Virginia
      • Richmond, Virginia, Forenede Stater, 23298
        • Children's Hospital of Richmond at Virginia Commonwealth University

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

18 år og ældre (Voksen, Ældre voksen)

Tager imod sunde frivillige

Ingen

Køn, der er berettiget til at studere

Alle

Beskrivelse

Inclusion Criteria:

Both members of the youth/parent dyad must meet all eligibility criteria

Young adults

  • English-speaking
  • patients in Pediatric Endocrinology at Children's Hospital of Richmond (CHoR) at Virginia Commonwealth University (VCU)
  • between ages 18-22 yrs with a
  • diagnosis of T1D for >1 year

Parents

  • greater than 18 years of age
  • provide care to the young adult with T1D
  • are willing to participate in the intervention

Medical providers

• provide care to patients with T1D ages 18-22 yrs in Pediatric Endocrinology at CHoR

Exclusion Criteria:

Young adults

  • significant psychiatric, cognitive, medical or developmental conditions that would impair their ability to complete assessments and/or engage in diabetes self-care behaviors (e.g., malignancies, psychosis, intellectual disability), as documented in the medical record or revealed during eligibility screening, or
  • medically-induced diabetes or diagnosis of diabetes other than type 1 diabetes

Parents

  • non-English speaking
  • psychiatric, cognitive, or developmental conditions that would impair their ability to complete assessments and/or engage in the intervention as determined at study screening

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: Støttende pleje
  • Tildeling: N/A
  • Interventionel model: Enkelt gruppeopgave
  • Maskning: Ingen (Åben etiket)

Våben og indgreb

Deltagergruppe / Arm
Intervention / Behandling
Eksperimentel: Transition preparation program
Transition preparation intervention for young adults with type 1 diabetes (T1D)
Adfærdsmæssigt: Transition preparation intervention
Young adult participants and parents will complete transition preparation sessions that include meeting with a health behavior coach for in-person sessions and review of materials sent electronically between study visits.

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Number of sessions attended
Tidsramme: 6 months
Number of study visits (attendance)
6 months
Number of session views
Tidsramme: 6 months
Number of opened electronic materials (e.g., opened messages in the patient health portal))
6 months
Program acceptability - young adult
Tidsramme: 9 months
Young adult report on satisfaction with the program via an exit survey
9 months
Program acceptability - parent
Tidsramme: 9 months
Parent report on satisfaction with the program via an exit survey
9 months
Program acceptability - provider
Tidsramme: 9 months
Provider report on satisfaction with the program via an exit survey
9 months

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Change in Glycemic control
Tidsramme: Baseline to 9 months
Measurement of hemoglobin A1c (A1c; reported as a percentage)
Baseline to 9 months
Diabetes-related hospitalizations
Tidsramme: 9 months
Participant report and medical record review of count of reported diabetes-related hospitalizations and complications
9 months
Change in adherence to diabetes care regimen
Tidsramme: Baseline to 9 months
Average of young adult and parent participant reports on the Diabetes Management Questionnaire (DMQ)
Baseline to 9 months
Change in transition readiness
Tidsramme: Baseline to 9 months
Average of young adult and parent participant reports on the Transition Readiness Assessment Questionnaire (TRAQ)
Baseline to 9 months

Andre resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Change in diabetes self-efficacy
Tidsramme: Baseline to 9 months
Participant (young adult) report on the Self-Efficacy for Diabetes Self-Management (SEDSM)
Baseline to 9 months
Change in diabetes quality of life
Tidsramme: Baseline to 9 months
Participant (young adult) report on the Pediatric Quality of Life Diabetes Module
Baseline to 9 months
Change in diabetes family responsibility
Tidsramme: Baseline to 9 months
Average of young adult and parent participant reports on the Diabetes Family Responsibility Questionnaire (DFRQ)
Baseline to 9 months
Change in diabetes family conflict
Tidsramme: Baseline to 9 months
Average of young adult and parent participant reports on the Diabetes Family Conflict Scale (DFCS)
Baseline to 9 months
Change in depression
Tidsramme: Baseline to 9 months
Participant (young adult) report on the Center for Epidemiologic Studies Depression Scale (CESD)
Baseline to 9 months
Change in young adult diabetes distress
Tidsramme: Baseline to 9 months
Participant (young adult) report on the Diabetes Distress Scale
Baseline to 9 months
Change in parent diabetes distress
Tidsramme: Baseline to 9 months
Participant (parent) report on the Diabetes Distress Scale for Parents of Teens with T1D
Baseline to 9 months
Change in autonomy support
Tidsramme: Baseline to 9 months
Participant (young adult) report on the autonomy support sub-scale of the Barriers to Diabetes Adherence Questionnaire
Baseline to 9 months
Change in problem solving
Tidsramme: Baseline to 9 months
Participant (young adult) report on the Diabetes Adherence Problem Solving Questionnaire
Baseline to 9 months

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Sponsor

Virginia Commonwealth University

Samarbejdspartnere

American Diabetes Association

Efterforskere

  • Ledende efterforsker: Laura Caccavale, PhD, Virginia Commonwealth University
  • Ledende efterforsker: Melanie Melanie, PhD, Virginia Commonwealth University

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Faktiske)

11. juli 2019

Primær færdiggørelse (Faktiske)

16. september 2020

Studieafslutning (Faktiske)

16. september 2020

Datoer for studieregistrering

Først indsendt

24. juni 2019

Først indsendt, der opfyldte QC-kriterier

24. juni 2019

Først opslået (Faktiske)

26. juni 2019

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

9. november 2020

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

5. november 2020

Sidst verificeret

1. november 2020

Mere information

Begreber relateret til denne undersøgelse

Nøgleord

Yderligere relevante MeSH-vilkår

Andre undersøgelses-id-numre

  • HM20015399
  • 1-19-PDF-041-R (Andet bevillings-/finansieringsnummer: American Diabetes Association)

Plan for individuelle deltagerdata (IPD)

Planlægger du at dele individuelle deltagerdata (IPD)?

INGEN

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ingen

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ingen

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Kliniske forsøg med Type 1 diabetes

Kliniske forsøg med Transition preparation intervention

Søg i lignende forsøg

Sponsorer og samarbejdspartnere

Medicinske tilstande

Narkotikainterventioner

CROs by country

CROs in Gabon

Betingelser

Sjældne sygdomme

Narkotikainterventioner

Kosttilskud

Sponsor / samarbejdspartnere

Placeringer

Abonner